SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,510.98 -338.64
(-0.65%)

Dow Jones

7,705.40 -59.01
(-0.76%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vani Commercials Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

538918

INE661Q01017

12.053913

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

32.44

23.85

EPS(TTM)

Face Value()

Div & Yield %

0.25

Back

Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter

Jul 31,2026

Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.63 crore during the previous quarter ended June 2025. Sales rose 10.14% to Rs 15183.55 crore in the quarter ended June 2026 as against Rs 13786.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	15183.55	13786.07	10
OPM %	29.10	31.20	-
PBDT	5041.62	4691.32	7
PBT	4302.90	3990.77	8
NP	2894.79	2278.63	27

72,529.07 -242.65 ( -0.33%)

51,510.98 -338.64 (-0.65%)

7,705.40 -59.01 (-0.76%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)